The BMJ Response to Reviewers: How to Write a Rebuttal That Survives the Hanging Committee (2026)
A pre-submission and post-decision rebuttal guide for The BMJ. Grounded in pre-submission reviews on The BMJ-targeted clinical manuscripts and The BMJ's public author resources.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A strong BMJ response to reviewers opens with a short letter to the editor summarizing the broad-clinical change you made, then answers every comment point by point with quoted reviewer text, the specific action you took, and a page and line reference for each manuscript change.
The BMJ runs open peer review, so your rebuttal is read by named expert reviewers, often a patient or public reviewer, and a statistical or clinical epidemiology editor, then weighed at the weekly manuscript meeting. Concede minor points, defend substantive science with evidence, and never argue without proof.
Run a BMJ rebuttal-readiness check before you resubmit, or work through this guide manually. For broader cluster context, see the BMJ journal overview.
The Manusights BMJ rebuttal scan. This guide explains what The BMJ's reviewers and manuscript committee expect from a response letter. The scan tells you whether YOUR rebuttal closes the broad-audience and methodological gaps before you resubmit. We have reviewed clinical manuscripts and response letters targeting The BMJ and peer general-medical venues; the patterns below are the same ones the journal's named reviewers and statisticians flag. 60-day money-back guarantee. We do not train models on your manuscript and delete it within 24 hours.
Method note. This page was reviewed against The BMJ author resources, the journal's published peer-review policy, and Manusights pre-submission review data on The BMJ-targeted clinical manuscripts (accessed June 6, 2026). It exists for one reason: use this guide before you resubmit, when a strong rebuttal still decides whether a revise-and-resubmit becomes an acceptance.
For reference, The BMJ caps Research articles at 4000 words of body text with a 250-word structured abstract, routes submissions through ScholarOne at mc.manuscriptcentral.com/bmj, and publishes Research with no author-facing charge under its subscription model while offering a gold open-access option with an APC of around £3,000.
What makes a BMJ response to reviewers different?
The single biggest mistake authors make at The BMJ is treating the rebuttal like a private negotiation. It is not. The BMJ runs open peer review: at least two expert reviewers sign their reports, their names are disclosed to you, and on acceptance the full review history and your responses are published alongside the article. Anyone reading the paper later can see how you handled criticism. That changes the writing job.
A defensive or dismissive reply that might pass quietly at a single-anonymized journal becomes part of the permanent, public record at The BMJ.
The second difference is who actually reads your response. At many journals a single handling editor weighs the rebuttal. At The BMJ, a research paper that survives external review and the clinical epidemiology assessment goes to the weekly manuscript meeting, the "hanging committee," where a statistician, an external editorial adviser, the handling editor, and the research team read and discuss the paper before a collective decision.
Your response letter has to satisfy that whole group, not one person. A rebuttal that placates the clinical reviewer but leaves the statistician's concern half-answered will stall in that room.
The BMJ reviewer culture: open review, patient reviewers, and a statistician in the room
The BMJ's reviewer culture has three features that shape how you write back, and most general rebuttal advice ignores all three.
Open, signed, published review. Reviewers know you will see their names, and they know their reports may be published. Reviews therefore tend to be measured and constructive, and the journal expects the same from you in return. Quote the reviewer's exact words, thank them where a comment genuinely improved the paper, and disagree only with evidence. The published-history posture rewards authors who engage substantively and quietly penalizes those who score points.
A patient or public reviewer. Since 2014 The BMJ has routinely included patient and public reviewers in peer review for research papers. A patient reviewer assesses whether the research question matters to patients and carers, whether the outcomes you measured are the ones patients care about, and whether the findings are usable for shared decision-making. Many authors skim this review because it does not read like a methods critique. That is a mistake.
If the patient reviewer says your patient-involvement statement is thin or your outcomes do not reflect patient priorities, the manuscript committee hears that, and at a journal built around broad clinical usefulness it carries weight. Respond to the patient or public reviewer as carefully as you respond to the clinical experts, in plain language, and show the specific change you made in the patient and public involvement section.
Clinical epidemiology and statistical review. Research papers at The BMJ are assessed for study design, statistical analysis, and analytical approach by a clinical epidemiology or statistics editor, and a statistician sits in the manuscript meeting. This is closer to JAMA's biostatistician filter than to a generalist read. If a statistical comment asks for a sensitivity analysis, a corrected confidence interval, or a different handling of missing data, you cannot wave it away in prose.
You have to run the analysis, report it, and point to the exact table or figure where the new result lives.
Key Insight
At The BMJ your rebuttal is read by named expert reviewers, a patient reviewer, and a statistician, then debated at the weekly manuscript meeting. Write it for a committee that includes a non-specialist and a statistician, not for one editor.
A copyable BMJ rebuttal-letter template
Use this structure. Replace the bracketed parts with your own content. Keep the letter to the editor short, then make the point-by-point section do the work. Quote each comment, state the action, give a page and line reference.
Dear Editor,
Thank you for the opportunity to revise our manuscript the manuscript title, reference
[BMJ-2026-XXXXXX], for The BMJ. We are grateful to the reviewers, the
patient reviewer, and the statistical reviewer for comments that have
materially improved the paper's broad clinical relevance and its
reporting.
The most substantive changes are: (1) we added a prespecified sensitivity analysis addressing the missing-outcome concern (Results, page 9, lines 210 to 224, and new Table 3); (2) we rewrote the abstract and Discussion to state the practice consequence for general clinicians, not only specialists (page 2, lines 30 to 41; page 12, lines 290 to 305); and (3) we strengthened the Patient and Public Involvement statement to describe how patient input shaped outcome selection (Methods, page 6, lines 138 to 149).
A point-by-point response follows. All manuscript changes are highlighted in the marked copy.
Yours sincerely,
[Corresponding author, on behalf of all authors]
----------------------------------------------------------------------
Reviewer 1 (named expert reviewer)
Comment 1.1: "The primary analysis does not account for loss to
follow-up, which exceeded 15% in the intervention arm."
Response: We agree. We have added a prespecified multiple-imputation
sensitivity analysis and a complete-case comparison. The effect estimate
is unchanged in direction and magnitude. Revised: Methods page 7,
lines 160 to 171; Results page 9, lines 210 to 224; new Table 3.
Comment 1.2: "The discussion overstates generalisability to primary
care."
Response: We have removed the primary-care claim and clarified the
sampled setting. Revised: Discussion page 12, lines 296 to 303.
Reviewer 2 (named expert reviewer)
Comment 2.1: "Reporting against the CONSORT checklist is incomplete;
several items point to 'see Methods' without a specific location."
Response: We have completed the CONSORT checklist with exact page and
line numbers for every item and uploaded it as a supplementary file.
Revised: see CONSORT checklist (supplementary) and Methods page 6 to 8.
Patient reviewer
Comment P.1: "It is not clear whether the outcomes measured matter to
patients living with this condition."
Response: We have expanded the Patient and Public Involvement statement
to describe how a patient advisory group selected the primary outcome and
reviewed the lay summary. Revised: Methods page 6, lines 138 to 149;
new lay summary, page 14.
Statistical reviewer
Comment S.1: "Confidence intervals are reported for the primary outcome
but omitted for the prespecified subgroups."
Response: We have added confidence intervals for all prespecified
subgroups and a test for interaction. Revised: Results page 10,
lines 232 to 248; Table 4.This template earns its place because it carries the four things the manuscript meeting looks for: an opening to the editor, a separate block for each named reviewer plus the patient and statistical reviewers, explicit action language ("we added," "we removed," "we clarified," "we expanded"), and a page and line reference for every change.
The page-and-line rule, stated plainly
Every change you claim must point to where it lives. Write "Revised: Results, page 9, lines 210 to 224" rather than "we have addressed this in the manuscript." A BMJ editor reconciling a 14-page rebuttal against a 30-page manuscript at the weekly meeting will not hunt for your edits. If they cannot find the change in seconds, the safe assumption in that room is that the change is weaker than you claim.
Reference the page and line in the revised manuscript, and if line numbers shifted between rounds, renumber against the current version so a reviewer can verify each citation instantly. Before you resubmit, a BMJ page-and-line citation check can confirm every claimed change resolves to a real location in the revised manuscript.
Typography: keep reviewer text and your response visually distinct
The committee reads many response letters. Make yours scannable. Use a clear typographic distinction between the reviewer's comment and your reply: put the quoted reviewer comment in bold or italic, and your author response in plain text, or use a colored or boxed block for one and not the other. Never let the reviewer's words and your reply run together in one undifferentiated paragraph.
A reviewer skimming to confirm their own comment was addressed should be able to find their text in under a second, then drop straight into your action and your page reference.
Tone calibration: what to write instead of what you want to write
The published-review posture at The BMJ punishes defensiveness more than at most journals. Calibrate every reply toward substance.
Reviewer comment | Bad response | Better response |
|---|---|---|
"The analysis ignores loss to follow-up." | "Our analysis is standard for this design and we see no need to change it." | "We agree. We added a prespecified multiple-imputation sensitivity analysis; the effect is unchanged (page 9, lines 210 to 224, Table 3)." |
"Generalisability to primary care is overstated." | "The reviewer has misunderstood our population." | "Thank you for catching this. We removed the primary-care claim and clarified the sampled setting (page 12, lines 296 to 303)." |
"The PPI statement is generic." | "Patient involvement is described as required." | "We expanded the PPI statement to show how a patient advisory group chose the primary outcome and reviewed the lay summary (page 6, lines 138 to 149)." |
"Subgroup confidence intervals are missing." | "Subgroups were exploratory, so intervals are unnecessary." | "We added confidence intervals and a test for interaction for all prespecified subgroups (page 10, lines 232 to 248, Table 4)." |
"The abstract is too specialist." | "The abstract follows our field's conventions." | "We rewrote the abstract to lead with the practice consequence for general clinicians (page 2, lines 30 to 41)." |
The pattern is consistent: agree where you can, act, and point to the location. Reserve genuine disagreement for the rare comment where you hold strong methodological or clinical-relevance evidence, and say so courteously, because the reviewer is named and the exchange may be published.
In our pre-submission review work with The BMJ submissions, the rebuttal fails before the science does
This guide tells you what The BMJ's reviewers and manuscript committee expect. The named patterns below come from the response letters and manuscripts we screen before authors resubmit to The BMJ and peer general-medical venues. The four that recur most are: the rebuttal that answers the clinician but not the statistician, the patient reviewer treated as a formality, the unmapped reporting checklist, and the defensive paragraph that becomes part of the public record.
Each one is visible in specific manuscript components before the revision is uploaded, and each is testable against your own draft.
The rebuttal that answers the clinical reviewer but not the statistician
This is the single most damaging named failure pattern we see, and it is rooted in The BMJ's editorial culture rather than in any one reviewer. In our analysis of The BMJ-targeted revisions, the most common failure is a response letter that handles the named clinical reviewers thoroughly and then disposes of the statistical analysis comment in a single sentence of prose.
At a journal with a clinical epidemiology assessment and a statistician in the manuscript meeting, that is the comment most likely to stall the paper. We see authors write "we have clarified our statistical approach" when the reviewer asked for a sensitivity analysis, a corrected confidence interval, or a different treatment of missing data.
The fix is mechanical: run the analysis the statistician asked for, report the new number in a named table or figure, and cite the exact page and line. A statistical comment is closed by a result, never by a paragraph.
The patient reviewer treated as a formality
In our pre-submission review work with clinical manuscripts targeting The BMJ, the second recurring pattern is a response that breezes past the patient or public reviewer. Authors write three pages to the experts and two lines to the patient reviewer, often a generic "we thank the reviewer for their helpful comments." The BMJ built patient involvement into peer review on purpose, and the manuscript committee notices when the patient-involvement statement is still thin after revision.
When a patient reviewer says the measured outcomes do not match patient priorities, the strong response shows a concrete change: how a patient advisory group shaped outcome selection, how the lay summary was revised, how recruitment materials changed. Answer the patient reviewer in plain language, and edit the patient and public involvement section so the change is real rather than rhetorical.
The reporting checklist that still says "see Methods"
In our pre-submission review work with The BMJ submissions, the third pattern is a revised manuscript whose reporting checklist (CONSORT, STROBE, PRISMA, or the relevant guideline) was never properly mapped. Reviewers at The BMJ check the checklist against the paper, and a checklist where half the items point vaguely to "see Methods" reads as immaturity to a committee that treats reporting discipline as part of research trust.
The strong revision completes every checklist item with an exact page and line in the revised manuscript and uploads it as a supplementary file, so a reviewer can verify each item in seconds rather than searching.
The defensive paragraph that becomes part of the public record
In our pre-submission review work with The BMJ-targeted response letters, the fourth pattern is tone. Because The BMJ publishes the review history, a defensive reply does not disappear after the decision; it stays attached to the paper. We flag responses that argue with the reviewer instead of with the evidence, that imply the reviewer misread the paper, or that decline a reasonable request without a methodological reason.
The fix is to convert every instinct to defend into either a revision or a courteous, evidence-backed disagreement that you would be comfortable seeing published next to your name.
If you want a manuscript-level read before you resubmit, a BMJ open-peer-review rebuttal check can test whether your response closes the statistical, patient-relevance, and reporting gaps the committee will weigh.
When to push back versus comply at The BMJ
Situation | Recommended approach |
|---|---|
Statistician requests a sensitivity analysis or corrected interval | Comply. Run it, report it in a named table, cite page and line. |
Reviewer requests an experiment or analysis outside the study scope | Push back courteously, justify the scope boundary, propose an alternative. |
Patient reviewer says outcomes do not match patient priorities | Comply where possible. Show the PPI-driven change explicitly. |
Reviewer flags a generalisability overclaim | Comply. Narrow the claim, clarify the setting. |
Reviewer challenges the core clinical-relevance case | Engage substantively. Defend with evidence or accept that the paper may fit a specialty journal better. |
Source: Manusights review of The BMJ-targeted resubmissions, plus The BMJ author resources (accessed June 2026).
Honest friction: rejection on revision is real at The BMJ
A revise-and-resubmit decision at The BMJ is not an acceptance in waiting. The journal desk-rejects roughly 80 to 85% of submissions, and a meaningful share of papers that reach revision are still rejected after the response letter, especially when the rebuttal fails to close the broad-audience or statistical gap.
The majority of revisions that fail do so for one of three reasons: the statistical concern was answered in prose rather than with a new analysis, the broad clinical-relevance case was restated rather than strengthened, or the response argued rather than revised.
Keep the comparison set in view while you revise. The BMJ editors triage and assess papers against the same broad-clinical bar that JAMA, NEJM, and The Lancet apply, but The BMJ weights primary care, public health, and patient involvement more heavily than its general-medical peers.
If your response cannot make the broad-audience case stronger than it was at first submission, the same finding that stalls at The BMJ may read as a clean fit at a specialty journal, where editors screen for depth in one field rather than reach across fields.
Two further cautions. First, a rebuttal cannot rescue a paper whose core finding is genuinely specialty-bound; if the manuscript meeting decides the work belongs in a specialist venue, no response letter changes that, and the honest move is to redirect to a journal such as a specialist BMJ title, BMC Medicine, or PLOS Medicine. Second, do not confuse a rebuttal with an appeal.
If The BMJ rejects after revision, an appeal is a separate, evidence-heavy process, not a louder version of the response letter. Treating a clear rejection as a rebuttal opportunity wastes the editor's goodwill. See the BMJ rejection and next-steps guide for the redirection decision.
How to prepare a BMJ response to reviewers
Revision task | What it produces |
|---|---|
Read every report, including the patient and statistical reviews | A complete list of comments, sorted by reviewer |
Cluster comments and identify the statistical and broad-audience asks | A revision plan that prioritizes the committee's likely sticking points |
Run requested analyses and revisions | New tables, figures, and statements with locations recorded |
Draft the point-by-point response with page and line references | A scannable letter the committee can verify quickly |
Co-author and statistician sign-off | A response every author can stand behind in the public record |
Source: Manusights internal review of The BMJ-targeted resubmissions, 2025 cohort. Last reviewed June 6, 2026.
Submit If
- every statistical comment is answered with a new analysis reported in a named table or figure, with a page and line reference, not with prose
- the patient or public reviewer's comment produced a real change in the patient and public involvement statement, the outcome selection, or the lay summary
- the reporting checklist (CONSORT, STROBE, or PRISMA) is fully mapped to exact page and line numbers in the revised manuscript
- the abstract and Discussion now lead with the practice consequence for general clinicians rather than specialty interest
- every reply would read as constructive if it were published next to your name in the open review history
Readiness check
Run the scan to see how your manuscript scores on these criteria.
See score, top issues, and what to fix before you submit.
Think Twice If
- a reviewer asked for a sensitivity analysis or a corrected confidence interval and your response says "we have clarified our statistical approach" without a new result
- your reply to the patient reviewer is a generic thank-you with no change to the patient and public involvement section
- the reporting checklist still points items to "see Methods" instead of a specific page and line
- the broad-audience case in the revised abstract is the same one that was already there at first submission
- the response argues with more than a third of the comments instead of revising, and the disagreements are not backed by methodological evidence
Frequently asked questions
Open the letter to the editor with a one-paragraph summary of the broad-clinical change you made, then respond point by point to each named expert reviewer, the patient or public reviewer, and any statistical-review comment separately. Quote each comment verbatim, state the action you took, and cite the page and line where the change appears. The BMJ's open peer review means your rebuttal is read by reviewers whose names are published, so the tone must be substantive rather than defensive.
Yes. The BMJ runs open peer review: at least two expert reviewers sign their reports, and on acceptance the reviews and your responses are published alongside the article. Many research papers also receive a patient or public reviewer and a clinical epidemiology or statistics review. Write the rebuttal knowing it will be read by named people and may appear in the published record.
Major-revision decisions at The BMJ typically allow around six weeks for a standard revision and up to roughly three months when substantive new analyses or data are requested. Ask the editorial office for an extension before the deadline rather than after it. A revised manuscript can be returned to the original reviewers or assessed afresh at the weekly manuscript meeting.
The hanging committee is The BMJ's weekly manuscript meeting where a statistician, an external editorial adviser, the handling editor, and the research team read and discuss a paper's importance, originality, and scientific quality before a collective decision. Your response to reviewers has to satisfy this group, not a single editor, so it must close the broad-audience and methodological gaps the reviewers raised.
You can push back, but only with evidence and only on substantive science. Concede minor and stylistic points and revise. Reserve disagreement for comments where you have a strong methodological or clinical-relevance argument, and present that argument courteously because the reviewer is named and the exchange may be published.
Sources
- The BMJ peer review process and policies, BMJ Author Hub (accessed June 2026)
- Resources for authors, The BMJ (accessed June 2026)
- Perspectives on involvement in the peer-review process: surveys of patient and public reviewers at two journals (PMC) (accessed June 2026)
- Opening up BMJ peer review (PMC) (accessed June 2026)
- Ten Simple Rules for Writing a Response to Reviewers, PLOS Computational Biology (accessed June 2026)
- Manusights internal pre-submission review corpus (The BMJ-targeted manuscripts, 2025 cohort)
Final step
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan. See score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Find out if this manuscript is ready to submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.